Scientific discovery in the age of artificial intelligence

H Wang, T Fu, Y Du, W Gao, K Huang, Z Liu… - Nature, 2023 - nature.com
Artificial intelligence (AI) is being increasingly integrated into scientific discovery to augment
and accelerate research, helping scientists to generate hypotheses, design experiments …

Artificial intelligence for drug discovery: Are we there yet?

C Hasselgren, TI Oprea - Annual Review of Pharmacology and …, 2024 - annualreviews.org
Drug discovery is adapting to novel technologies such as data science, informatics, and
artificial intelligence (AI) to accelerate effective treatment development while reducing costs …

Evaluating explainability for graph neural networks

C Agarwal, O Queen, H Lakkaraju, M Zitnik - Scientific Data, 2023 - nature.com
As explanations are increasingly used to understand the behavior of graph neural networks
(GNNs), evaluating the quality and reliability of GNN explanations is crucial. However …

Machine learning for synthetic data generation: a review

Y Lu, M Shen, H Wang, X Wang, C van Rechem… - arXiv preprint arXiv …, 2023 - arxiv.org
Machine learning heavily relies on data, but real-world applications often encounter various
data-related issues. These include data of poor quality, insufficient data points leading to …

A knowledge-guided pre-training framework for improving molecular representation learning

H Li, R Zhang, Y Min, D Ma, D Zhao, J Zeng - Nature Communications, 2023 - nature.com
Learning effective molecular feature representation to facilitate molecular property prediction
is of great significance for drug discovery. Recently, there has been a surge of interest in pre …

Application of variational graph encoders as an effective generalist algorithm in computer-aided drug design

HYI Lam, R Pincket, H Han, XE Ong, Z Wang… - Nature Machine …, 2023 - nature.com
Although there has been considerable progress in molecular property prediction in
computer-aided drug design, there is a critical need to have fast and accurate models. Many …

Reinforced genetic algorithm for structure-based drug design

T Fu, W Gao, C Coley, J Sun - Advances in Neural …, 2022 - proceedings.neurips.cc
Abstract Structure-based drug design (SBDD) aims to discover drug candidates by finding
molecules (ligands) that bind tightly to a disease-related protein (targets), which is the …

Bidirectional learning for offline infinite-width model-based optimization

C Chen, Y Zhang, J Fu, XS Liu… - Advances in Neural …, 2022 - proceedings.neurips.cc
In offline model-based optimization, we strive to maximize a black-box objective function by
only leveraging a static dataset of designs and their scores. This problem setting arises in …

[HTML][HTML] First fully-automated AI/ML virtual screening cascade implemented at a drug discovery centre in Africa

G Turon, J Hlozek, JG Woodland, A Kumar… - Nature …, 2023 - nature.com
Streamlined data-driven drug discovery remains challenging, especially in resource-limited
settings. We present ZairaChem, an artificial intelligence (AI)-and machine learning (ML) …

TOXRIC: a comprehensive database of toxicological data and benchmarks

L Wu, B Yan, J Han, R Li, J Xiao, S He… - Nucleic Acids …, 2023 - academic.oup.com
The toxic effects of compounds on environment, humans, and other organisms have been a
major focus of many research areas, including drug discovery and ecological research …